Category: Neurology

Chronic pain affects more than one-quarter of adults in the United States. This debilitating level of pain is difficult to treat for a number of

Three separate research studies point to a small protein, platelet-derived chemokine platelet factor 4 (PF4), as a possible tool for combating cognitive decline in aging

In announcing positive results from a trial evaluating donanemab, Eli Lilly reported that the monoclonal antibody drug slowed cognitive decline among people with Alzheimer’s disease. The study

What happens in the brain on the verge of death? For hundreds of years, stories told by people who have come back from the brink

Building on previous research that showed how epidural electrical stimulation (EES) can help restore walking ability in people with spinal cord injuries, neuroscientists have now

Neurodegenerative diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease, are often associated with the build-up of cellular debris, like misfolded proteins, within the brain.

Human brains consist of around 86 billion neurons that connect and communicate with each other, forming an intricate network. Understanding how the human brain functions

As many as 30,000 people in the United States are currently diagnosed with amyotrophic lateral sclerosis, or ALS. This debilitating neurological condition is caused by

According to the Global Burden of Disease study, 6.2 million patients live with Parkinson’s disease (PD) and this number is expected to double by 2040.

Parkinson’s Disease (PD) is a progressive neurodegenerative disease that causes neurons in the area of the brain that controls movement to weaken or die. Up

Discovering effective and safe new drugs depends on a detailed knowledge of disease mechanisms, as well as a successful progression from candidate identification to clinical

The common marmoset, Callithrix jaccus, possesses complex social behaviors and sleep patterns that closely resemble those of humans. This South American monkey’s metabolism, immune systems,

In the April 27th issue of JAMA Neurology, researchers released new data that suggests 18F-flortaucipir positron emission topography (PET) can help clinicians diagnose late-stage Alzheimer’s Disease (AD).

According to a study published in Alzheimer’s & Dementia, cognitive decline and the deposition of harmful proteins in the brain linked to Alzheimer’s Disease (AD)

Researchers have designed an antibody that can identify toxic particles that destroy healthy brain cells. A collaboration of scientists from the University of Cambridge, University

RNA sequencing studies of thousands of post mortem human brain samples have generated massive datasets for use in medical research. These studies implicate many different